Literature DB >> 17713308

Addressing cultural barriers to the successful use of insulin in Hispanics with type 2 diabetes.

Carlos Campos1.   

Abstract

Hispanics experience a higher rate of diabetes than non-Hispanic whites and tend to have worse glycemic control and a greater risk of diabetes-related complications. Once oral antidiabetic agents become insufficient, insulin plays an important role in achieving glycemic goals. However, many Hispanic patients are resistant to initiating insulin therapy or hesitant to increase doses, as necessary, to control their glucose levels. Barriers to insulin therapy include socioeconomic issues (eg, cost, insurance status), language difficulties, poor health literacy, and cultural beliefs that impact the patient-provider relationship and negatively affect patients' perceptions of diabetes and insulin. Healthcare providers can help overcome these issues and improve patient-provider communication by practicing culturally competent care. Implementation of a simple titration regimen using once-daily basal insulin may enable Hispanic patients to maintain glycemic control and improve outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713308     DOI: 10.1097/SMJ.0b013e3180f609c4

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  21 in total

1.  Efficacy and Safety of Canagliflozin in Type 2 Diabetes Patients of Different Ethnicity.

Authors:  Jaime A Davidson; Richard Aguilar; Fernando J Lavalle González; Angelina Trujillo; Maria Alba; Ujjwala Vijapurkar; Gary Meininger
Journal:  Ethn Dis       Date:  2016-04-21       Impact factor: 1.847

2.  Type 2 diabetes self-management social support intervention at the U.S.-Mexico border.

Authors:  Marylyn Morris McEwen; Alice Pasvogel; Gwen Gallegos; Lourdes Barrera
Journal:  Public Health Nurs       Date:  2010 Jul-Aug       Impact factor: 1.462

3.  The provision of diabetes-monitoring exams to older Latinos.

Authors:  Angelica P Herrera; Matthew Lee Smith; Marcia G Ory; Hector P Rodriguez; Ruth Warre; Wesley K Thompson; Annette Azcue; Jairo A Romero
Journal:  J Aging Health       Date:  2011-10

Review 4.  A Framework for Addressing Diabetes-Related Disparities in US Latino Populations.

Authors:  Ivan Marquez; Neil Calman; Casey Crump
Journal:  J Community Health       Date:  2019-04

5.  Influence of Language and Culture in the Primary Care of Spanish-Speaking Latino Adults with Poorly Controlled Diabetes: A Qualitative Study.

Authors:  Cindy D Zamudio; Gabriela Sanchez; Andrea Altschuler; Richard W Grant
Journal:  Ethn Dis       Date:  2017-12-07       Impact factor: 1.847

6.  The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.

Authors:  Aramesh Saremi; Dawn C Schwenke; Gideon Bahn; Ling Ge; Nicholas Emanuele; Peter D Reaven
Journal:  Metabolism       Date:  2014-10-17       Impact factor: 8.694

7.  A Tale of Two Stories: An Exploration of Identification, Message Recall, and Narrative Preferences Among Low-Income, Mexican American Women.

Authors:  Rachel E Davis; Sonya Dal Cin; Suzanne M Cole; Ligia I Reyes; Shannon J McKenney-Shubert; Nancy L Fleischer; Lynna Chung Densen; Karen E Peterson
Journal:  Health Commun       Date:  2016-10-21

8.  Latina patient perspectives about informed treatment decision making for breast cancer.

Authors:  Sarah T Hawley; Nancy K Janz; Ann Hamilton; Jennifer J Griggs; Amy K Alderman; Mahasin Mujahid; Steven J Katz
Journal:  Patient Educ Couns       Date:  2008-11

Review 9.  Psychological insulin resistance: patient beliefs and implications for diabetes management.

Authors:  Meryl Brod; Jens Harald Kongsø; Suzanne Lessard; Torsten L Christensen
Journal:  Qual Life Res       Date:  2008-11-28       Impact factor: 4.147

10.  Perceptions of barriers in managing diabetes: perspectives of Hispanic immigrant patients and family members.

Authors:  Jie Hu; Karen Amirehsani; Debra C Wallace; Susan Letvak
Journal:  Diabetes Educ       Date:  2013-05-02       Impact factor: 2.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.